We specialize in providing you with information and consultative analysis to answer your early commercialization business questions with actionable insights. Our strength is in helping you right-size your U.S. market opportunity by using multiple data sources. We help you make sense of mounds of data, integrating and interpreting the analyses, to properly size and characterize un-served and under-served patient populations appropriate for your drug or device.

Thomson Reuters has both payer and provider data assets that together offer a thorough, multi-dimensional view of your market opportunity. Rapid-response online tools provide broad insights into prevalence rates, inpatient/outpatient volume, and trends allowing you to quickly identify promising market segments. Custom projects mine our rich databases to deliver expert analysis and interpretation to help you make informed marketing decisions.

Benefits

  • Expertise in interpreting data from multiple sources to right-size your market
  • Rapid-response online tools allow you to quickly gain high-level insights
  • Multiple data sources provide a thorough, multi-dimensional view of market opportunities
  • Strong facility-level tracking allows the identification of opportunities for changes in therapy, which frequently happen while in the hospital
  • With over 10 years of data, historical analysis combined with current usage rates and trends can be overlaid onto expected demographic changes to forecast future market size